1. Home
  2. HTHT vs RDY Comparison

HTHT vs RDY Comparison

Compare HTHT & RDY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo H World Group Limited

HTHT

H World Group Limited

HOLD

Current Price

$42.45

Market Cap

13.6B

ML Signal

HOLD

Logo Dr. Reddy's Laboratories Ltd

RDY

Dr. Reddy's Laboratories Ltd

HOLD

Current Price

$15.40

Market Cap

11.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HTHT
RDY
Founded
2005
1984
Country
China
India
Employees
N/A
N/A
Industry
Hotels/Resorts
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.6B
11.9B
IPO Year
2010
2001

Fundamental Metrics

Financial Performance
Metric
HTHT
RDY
Price
$42.45
$15.40
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
1
Target Price
$56.60
$16.90
AVG Volume (30 Days)
2.4M
1.9M
Earning Date
05-19-2026
05-12-2026
Dividend Yield
4.07%
0.52%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$7.18
$7.72
Revenue Next Year
$6.71
$3.50
P/E Ratio
$30.34
$18.67
Revenue Growth
N/A
N/A
52 Week Low
$30.42
$12.19
52 Week High
$56.53
$15.27

Technical Indicators

Market Signals
Indicator
HTHT
RDY
Relative Strength Index (RSI) 36.46 78.69
Support Level $42.07 $13.80
Resistance Level $45.65 N/A
Average True Range (ATR) 1.26 0.29
MACD -0.07 0.23
Stochastic Oscillator 31.81 85.91

Price Performance

Historical Comparison
HTHT
RDY

About HTHT H World Group Limited

H World Group Ltd a foremost, fast-growing multi-brand hotel group with international operations. The principal business activities of the Company are to develop and operate leased and owned, manachised and franchised hotels mainly in the PRC or PRC Mainland. The Group has two operating segments which are legacy Huazhu and legacy DH according to the way management intends to evaluate results and allocate resources within the Group. The majority of revenue comes from legacy Huazhu. The company has presence in Greater China and also Outside Greater China.

About RDY Dr. Reddy's Laboratories Ltd

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly 40% of its generics sales, with other key markets being India (20%) and Europe (20%). Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

Share on Social Networks: